We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.35%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+16.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$9.38B
Cap. Flow %
6.92%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Energy 8.49%
2 Technology 6.67%
3 Healthcare 6.67%
4 Financials 6.58%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISD
3601
PGIM High Yield Bond Fund
ISD
$419M
$979K ﹤0.01%
58,543
-29,011
-33% -$501K
ENH
3602
DELISTED
Endurance Specialty Holdings Ltd
ENH
$979K ﹤0.01%
17,741
+17,476
+6,595% +$967K
DGAS
3603
DELISTED
Delta Natural Gas Co Inc
DGAS
$977K ﹤0.01%
49,443
-795
-2% -$16.1K
RGP
3604
PUT
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$975K ﹤0.01%
29,900
+28,600
+2,200% +$907K
KW
3605
DELISTED
Kennedy-Wilson Holdings
KW
$973K ﹤0.01%
40,574
-66,356
-62% -$1.68M
IBKC
3606
DELISTED
IBERIABANK Corp
IBKC
$973K ﹤0.01%
15,553
+689
+5% +$45.5K
AET
3607
CALL
DELISTED
Aetna Inc
AET
$972K ﹤0.01%
12,000
-9,400
-44% -$765K
GEQ
3608
DELISTED
Gugnheim Eql Wght Enh Eqty In Fd
GEQ
$970K ﹤0.01%
49,110
+6,514
+15% +$129K
SO icon
3609
CALL
Southern Company
SO
$107B
$969K ﹤0.01%
22,200
+5,200
+31% +$228K
DRTX
3610
PUT
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$969K ﹤0.01%
76,400
+1,000
+1% +$14.9K
ASPS icon
3611
CALL
Altisource Portfolio Solutions
ASPS
$65.8M
$968K ﹤0.01%
1,200
+1,075
+860% +$876K
NSM
3612
DELISTED
Nationstar Mortgage Holdings
NSM
$967K ﹤0.01%
28,261
-134,977
-83% -$4.48M
ASEI
3613
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
$967K ﹤0.01%
17,457
+1,627
+10% +$99.8K
EMCD
3614
DELISTED
SPDR SER TR SPDR BOFA M.L. EMERGING MKTS CORP BD ETF
EMCD
$966K ﹤0.01%
32,187
+29,888
+1,300% +$915K
PACW
3615
DELISTED
PacWest Bancorp
PACW
$964K ﹤0.01%
23,381
-40,125
-63% -$1.68M
POWI icon
3616
Power Integrations
POWI
$3.61B
$963K ﹤0.01%
35,724
-1,128
-3% -$31.8K
MBI icon
3617
MBIA
MBI
$260M
$962K ﹤0.01%
104,814
-71,034
-40% -$698K
CDE icon
3618
PUT
Coeur Mining
CDE
$17.9B
$961K ﹤0.01%
193,800
+186,200
+2,450% +$1.43M
PHT
3619
DELISTED
Pioneer High Income Fund
PHT
$961K ﹤0.01%
56,655
+4,511
+9% +$80K
CWCO icon
3620
Consolidated Water Co
CWCO
$488M
$959K ﹤0.01%
82,160
-65,691
-44% -$756K
MQT
3621
DELISTED
BlackRock MuniYield Quality Fund II
MQT
$959K ﹤0.01%
75,035
+13,694
+22% +$175K
USA icon
3622
Liberty All-Star Equity Fund
USA
$1.85B
$959K ﹤0.01%
164,515
+15,251
+10% +$90.5K
URA icon
3623
Global X Uranium ETF
URA
$6.27B
$957K ﹤0.01%
36,916
+18,531
+101% +$542K
PMO
3624
Franklin Municipal Opportunities Trust
PMO
$285M
$955K ﹤0.01%
81,604
+10,275
+14% +$120K
ESI
3625
PUT
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
$955K ﹤0.01%
222,500
+220,300
+10,014% +$2.29M

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.